This study evaluates the Pink & Pearl Campaign effect on lung cancer screening.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT06898333.
Locations matching your search criteria
United States
Missouri
Saint Louis
Siteman Cancer Center at Washington UniversityStatus: Active
Contact: Beryne M. Odeny
Phone: 314-362-1183
PRIMARY OBJECTIVES:
I. To determine the baseline prevalence of lung cancer screening (LCS) eligible women who present for screening mammography and opt-in to LCS, in BJC West County between March 1, 2025, and August 30, 2025.
II. To assess the effectiveness of the Pink and Pearl Campaign on increasing uptake of LCS among women undergoing mammography in BJC West County.
IIa. Using a pre-post design, we will assess the increase in number of women referred from the breast radiology service who successfully complete LCS before and after implementation of the Pink and Pearl campaign.
IIb. To determine the median “time-to-screening” and covariates of “time-to-screening.”
IIc. To determine the prevalence of women who underwent LCS through the Pink and Pearl campaign that have low-dose CT (LDCT)-detected lung nodules requiring further workup, and/or biopsy proven lung cancer.
III. To assess factors influencing LCS uptake and implementation outcomes of the Pink and Pearl campaign.
OUTLINE: This is an observational study.
GROUP I: Patients have their medical records reviewed on study.
GROUP II: Patients complete a survey on study.
GROUP III: Patients and healthcare providers complete an interview on study.
Trial PhaseNo phase specified
Trial Typescreening
Lead OrganizationSiteman Cancer Center at Washington University
Principal InvestigatorBeryne M. Odeny